Autor: |
Hiromichi Kawasaki, Takashi Takeuchi, Filippo Ricciardiello, Angela Lombardi, Elia Biganzoli, Marco Fornili, Davide De Bortoli, Massimo Mesolella, Alessia Maria Cossu, Marianna Scrima, Rosanna Capasso, Michela Falco, Giovanni Motta, Gaetano Motta, Domenico Testa, Stefania De Luca, Flavia Oliva, Teresa Abate, Salvatore Mazzone, Gabriella Misso, Michele Caraglia |
Jazyk: |
angličtina |
Rok vydání: |
2020 |
Předmět: |
|
Zdroj: |
Molecular Therapy: Nucleic Acids, Vol 20, Iss , Pp 711-724 (2020) |
Druh dokumentu: |
article |
ISSN: |
2162-2531 |
DOI: |
10.1016/j.omtn.2020.04.006 |
Popis: |
Laryngeal cancer (LCa), a neoplasm of the head and neck region, is a leading cause of death worldwide. Surgical intervention remains the mainstay of LCa treatment, but a crucial point is represented by the possible nodal involvement. Therefore, it is urgently needed to develop biomarkers and therapeutic tools able to drive treatment approaches for LCa. In this study, we investigated deregulated microRNAs (miRNAs) in tissues from LCa patients with either lymph node metastases (N+) or not (N−). miRNA expression profiling was performed by a comprehensive PCR array and subsequent validation by RT-qPCR. Results showed a significant decrease of miR-449a expression in N+ compared to N− patients, and miR-133b down-modulation in LCa tissues compared to paired normal ones. Receiver operating characteristic (ROC) curve analysis revealed the potential diagnostic power of miR-133b for LCa detection. According to the validation results, we selected miR-449a for further in vitro studies. Ectopic miR-449a expression in the LCa cell line Hep-2 inhibited invasion and motility in vitro, slowed cell proliferation, and induced the downregulation of Notch1 and Notch2 as direct targets of miR-449a. Collectively, this study provides new promising biomarkers for LCa diagnosis and a new opportunity to use miR-449a for the treatment of nodal metastases in LCa patients. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|